We are live on ! Find out more
OMED

OncoMed Pharmaceuticals, Inc.
OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

Back to rankings

53 hedge funds and large institutions have $66.3M invested in OncoMed Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
+$19.6M
2
BI
BVF Inc
California
+$7.26M
3
CII
CR Intrinsic Investors
Connecticut
+$5.01M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$4.98M
5
Primecap Management
Primecap Management
California
+$4.53M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$423K +$512K +27,644 New
JG
27
Jefferies Group
New York
$405K +$491K +26,480 New
UBS AM
28
UBS AM
Illinois
$402K +$487K +26,273 New
Northern Trust
29
Northern Trust
Illinois
$358K +$433K +23,366 New
Ameriprise
30
Ameriprise
Minnesota
$207K +$250K +13,500 New
Goldman Sachs
31
Goldman Sachs
New York
$206K +$249K +13,459 New
Charles Schwab
32
Charles Schwab
California
$188K +$220K +11,885 New
BIM
33
BlackRock Investment Management
Delaware
$185K +$224K +12,090 New
HCM
34
Hodges Capital Management
Texas
$184K +$222K +12,000 New
Morgan Stanley
35
Morgan Stanley
New York
$157K +$190K +10,241 New
TCIM
36
TIAA CREF Investment Management
New York
$154K +$187K +10,080 New
NFA
37
Nationwide Fund Advisors
Ohio
$123K +$149K +8,052 New
BA
38
BlackRock Advisors
Delaware
$119K +$145K +7,799 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$104K +$126K +6,800 New
Wells Fargo
40
Wells Fargo
California
$100K +$120K +6,502 New
BG
41
BlackRock Group
United Kingdom
$91K +$110K +5,919 New
BJ
42
BlackRock Japan
Japan
$83K +$101K +5,431 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$80K +$95.9K +5,175 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$77K +$92.6K +5,000 New
TA
45
Teachers Advisors
New York
$68K +$82.5K +4,450 New
SO
46
STRS Ohio
Ohio
$32K +$38.9K +2,100 New
MCM
47
Mazama Capital Management
Oregon
$31K +$37.9K +2,046 New
AIG
48
American International Group
New York
$17.9K +$21.7K +1,170 New
U
49
UBS
Switzerland
$17K +$20.6K +1,110 New
Barclays
50
Barclays
United Kingdom
$4K +$4.91K +265 New
1
2
3

OMED Hedge Fund Activity: Q3 2013 in Review

53 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in OncoMed Pharmaceuticals, Inc. (OMED) for Q3 2013, worth a combined $66.3M.

Buyers outnumbered sellers: 53 funds opened new OMED positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sectoral Asset Management, opening a new position worth an estimated $19.6M.

  • 53 institutional investors held OncoMed Pharmaceuticals, Inc. (OMED) as of Q3 2013, up from 0 in Q2 2013.
  • Funds reported $66.3M of OncoMed Pharmaceuticals, Inc. stock for Q3 2013.
  • 53 funds opened new OncoMed Pharmaceuticals, Inc. positions in Q3 2013 and 0 closed out, a net change of +53 holders.
  • The largest OncoMed Pharmaceuticals, Inc. buyer in Q3 2013 was Sectoral Asset Management, an estimated $19.6M added.

Based on aggregated 13F filings for Q3 2013.